Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02749955 · ClinicalTrials.gov registry record · NA
Partner Services Pre-exposure Prophylaxis (PS-PrEP)
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT02749955: Completed NA study, sponsored by University of Chicago.
NCT02749955 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 164 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02749955, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
This study evaluates the feasibility (reach, adoption, safety and implementation) and initial efficacy (higher linkage to care) of the Partner Services Pre-exposure Prophylaxis (PS-PrEP) intervention versus phone based Pre-exposure Prophylaxis (PrEP) treatment at 3 months post randomization among a sample of high risk individuals 18 - 35 years from clinic-based recruitment and internal referrals from social network based projects. The evaluation of the intervention will be used to strengthen routine department of public health services linkage to PrEP care.
Primary Outcome
Comparing 60 individuals who receive enhanced personalized linkage to care with a social worker to 60 individuals who receive routine phone based PrEP linkage.
Interventions
- BEHAVIORAL PS-PrEP Intervention Group
- BEHAVIORAL PrEPLine Control Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-07-30 |
| Phase | NA |
What the finished NCT02749955 record still lists
NCT02749955 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which PS-PrEP Intervention Group is the first listed.
NCT02749955 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02749955 about?
NCT02749955 is a clinical study titled "Partner Services Pre-exposure Prophylaxis (PS-PrEP)". This study evaluates the feasibility (reach, adoption, safety and implementation) and initial efficacy (higher linkage to care) of the Partner Services Pre-exposure Prophylaxis (PS-PrEP) intervention versus phone based Pre-exposure Prophylaxis (PrEP) treatment at 3 months post randomization among a ...
What is the current status of trial NCT02749955?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2015-11. Estimated completion is 2018-07-30.
What interventions are being tested in trial NCT02749955?
The interventions under investigation include: PS-PrEP Intervention Group (BEHAVIORAL), PrEPLine Control Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02749955?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02749955's enrollment target sits among peer trials
164 626th of 2000 higher than 1,374 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia